Student Accomplishments

Abstracts Accepted for Poster Presentations:

September 2005- Montreal, Canada
International Society for Chemotherapy –Community Acquired Pneumonia

Reese A, Zhanel GG, Hoban DJ and Noreddin AM. Pharmacodynamic Target Attainment Analysis of Garenoxacin Compared to Gemifloxacin, Moxifloxacin, Gatifloxacin and Levofloxacin versus S. pneumoniae in Serum and Epithelial Lining Fluid of Patients with Community Acquired Pneumonia. Abstract ISC-CAP 2005 #P001.

Noreddin AM, Reese AM, Hoban DJ and Zhanel GG. Pharmacodynamic Profiling of Telithromycin 800mg Once Daily, Azithromycin 500/250mg Once Daily and Clarithromycin 500mg Twice Daily in Plasma and Epithelial Lining Fluid versus S. pneumoniae: Monte Carlo Simulation Study of Patients with Community Acquired Pneumonia. Abstract ISC-CAP 2005 #P005.

October 2005- San Francisco, California
American College of  Clinical Pharmacology

Noreddin AM, Reese A, Ostroski M, Haynes V, Marras T, Chan C, Hoban DJ and Zhanel GG. Monte Carlo Simulation of Bacterial Activity versus P. aeruginosa of Levofloxacin 500mg, 750mg and 1000mg Once Daily Compared to Gatifloxacin 400mg Once Daily Administered to Critically Ill Patients. Abstract ACCP 2005 #332 E.

Noreddin AM, Haynes VL, Ajide N, Anderson B, Marras T, Chan C, Hoban DJ and Zhanel GG. Monte Carlo Simulation versus S. pneumoniae of Levofloxacin 500mg, 750mg and 1000mg Once Daily Compared to Gatifloxacin 200mg and 400mg Once Daily Administered to Hospitalized Patients with Community Acquired Pneumonia (CAP):  Dose and Age Stratification Study. Abstract ACCP 2005 #189E.

Fellowships and Grants

Samuel W. Melendy Undergraduate Research Scholarship recipient - Angela Reese, PDIII student and DCCTR member, summer 2005